Enamel hydroxyapatite mineral matrix and oral plaque bacteria

The enamel hydroxyapatite mineral matrix and oral plaque bacteria represent a complex therapeutic target central to oral health and the prevention of dental caries (NIH, 2023). Enamel is primarily composed of hydroxyapatite crystals, which undergo dynamic demineralization and remineralization cycles influenced by the surrounding oral environment (StatPearls, 2023). Oral plaque bacteria, particularly acidogenic species like Streptococcus mutans, form a biofilm on this mineral surface and metabolize dietary sugars into organic acids, leading to mineral loss (PubMed, 2021). Therapeutic interventions target this interface by either strengthening the mineral matrix against acid dissolution or by reducing the microbial load and metabolic activity within the biofilm (NIH, 2023). Fluoride is the most prominent agent, acting to convert hydroxyapatite into the more stable fluorapatite while also inhibiting bacterial enzymes (StatPearls, 2023). Understanding the interaction between the inorganic tooth structure and the organic microbial community is essential for developing effective treatments for tooth decay and periodontal diseases (PubMed, 2022).

Other names

Dental enamelTooth mineral matrixDental plaque biofilmCariogenic biofilmHydroxyapatite-biofilm interface

Drugs targeting this complex work through two primary pathways: the chemical modification of the mineral matrix to increase acid resistance (e.g., fluoride-induced formation of fluorapatite) and the inhibition of bacterial metabolism or viability within the plaque biofilm (e.g., antimicrobial action of chlorhexidine) (StatPearls, 2023; PubMed, 2021). Fluoride also promotes remineralization by attracting calcium and phosphate ions back into the enamel lattice (NIH, 2023).